Noradrenergic changes, aggressive behavior, and cognition in patients with dementia

Biological Psychiatry
Kim L MatthewsP T Francis

Abstract

We wished to examine the integrity of the noradrenergic system in patients with Alzheimer's disease, mixed/other dementias and controls, and possible relationships between changes in the noradrenergic system and the presence of behavioral and psychiatric signs and symptoms in dementia. Alpha(2) adrenoceptor sites were measured by radioligand binding in three cortical regions of 46 individuals with dementia and 33 elderly normal controls together with cortical noradrenaline concentration and locus coeruleus cell and neurofibrillary tangle counts. The alpha(2) adrenergic receptor density was unaltered in patients with Alzheimer's disease, mixed/other dementias compared with controls; however, there was a loss of locus coeruleus cells in subjects with dementia, reaching 50% within the rostral nucleus. In addition, a significant reduction was seen in the midtemporal cortical noradrenaline concentration (31% decrease) in patients with Alzheimer's disease. In subjects with dementia, there was a positive correlation between aggressive behavior and magnitude of rostral locus coeruleus cell loss, while the reduction in noradrenaline concentration correlated with cognitive impairment. Subgroups of patients with Alzheimer's disease may ha...Continue Reading

References

Feb 1, 1990·Archives of Neurology·G S ZubenkoU Kopp
Nov 1, 1988·Archives of Neurology·G S Zubenko, J Moossy
Nov 1, 1985·Journal of Pharmacological Methods·G A McPherson
Feb 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·R MongeauP Blier

❮ Previous
Next ❯

Citations

Sep 1, 2005·Current Neurology and Neuroscience Reports·Dag AarslandClive Ballard
Sep 19, 2002·Trends in Pharmacological Sciences·Alan M Palmer
Apr 12, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Beverly M FrancisHoward T J Mount
Sep 12, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Zhentao ZhangKeqiang Ye
Mar 17, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael T HenekaMarkus P Kummer
Jan 6, 2007·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Mattias HaglundElisabet Englund
Jan 23, 2014·BMC Health Services Research·Oana DanilaNathalie Jetté
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Sarah J CertelEdward A Kravitz
Aug 19, 2014·BioMed Research International·Xiao-Ling LiLan Tan
Feb 21, 2016·Trends in Cognitive Sciences·Mara Mather, Carolyn W Harley
Dec 3, 2010·Annales Françaises D'anesthèsie Et De Rèanimation·D AndréF Sztark
Jul 27, 2010·Behavioural Brain Research·Gaukhman AlexanderChristopher Janus
Feb 17, 2010·Neuropharmacology·Paul T FrancisMitchell K Lai
Feb 19, 2008·Behavioural Brain Research·Doretta CaramaschiJaap M Koolhaas
Nov 7, 2006·Progress in Neurobiology·Brice J WilliamsAnn-Charlotte Granholm
Jul 13, 2005·Neuropathology and Applied Neurobiology·A SyedM M Esiri
Mar 18, 2005·Neuropathology and Applied Neurobiology·R M CravenM M Esiri
Mar 24, 2016·Ageing Research Reviews·Nicola MammarellaBeth Fairfield
Feb 18, 2012·Neurobiology of Aging·Qinxi GuoNicholas John Justice
Jun 29, 2004·Psychoneuroendocrinology·Nathan HerrmannLyla R Khan
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Saima HilalMohammad Kamran Ikram
Dec 1, 2015·Neurobiology of Stress·Jennifer A RossElisabeth J Van Bockstaele
Jul 6, 2005·Neurobiology of Aging·Monica Garcia-AllozaMaría J Ramirez
Jun 1, 2005·Behavioural Brain Research·Melissa D MarinoDavid Weinshenker
Oct 2, 2003·Expert Opinion on Investigational Drugs·Sheila A Doggrell, Suzanne Evans
Nov 20, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Yannick VermeirenPeter P De Deyn
May 28, 2013·Neuroscience and Biobehavioral Reviews·Ludwig TrilloAhmad Salehi
Jun 25, 2008·Neurobiology of Aging·Daniel InsuaPedro Pesini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here